Namita Mitra

Namita Mitra

BVSc Veterinary Sciences, MVSc Veterinary Microbiology, PhD Animal Biotechnology, ACVM Diplomate-Virology

After earning a bachelor’s degree in Veterinary Sciences and Animal Health  (BVSc) in 2007, Namita went on to pursue a Master of Veterinary Microbiology from GADVASU, India. Her Master’s research on the molecular and histopathological diagnosis of avian oncogenic viruses in poultry brought her two national awards.

See more

In 2013, she was conferred a doctoral degree in Animal Biotechnology that concluded with her research findings on expression profiling of apoptosis-associated genes in canine mammary tumors. Right after her graduation, Namita worked as Assistant Professor of Animal Biotechnology and taught the courses of Animal Cell Culture, Animal Genetic Engineering, and Molecular Immunology.

A year later, she moved to the USA and joined as a research assistant in the Kansas State Veterinary Diagnostic lab. There, she worked on next-generation sequencing and data analysis with an emphasis on viral metagenomics. Driven by her deep interest in virology, she studied for the ‘American College of Veterinary Microbiologists (ACVM) board exam’ and in Dec 2018,  she was awarded ACVM Virology- diplomate status by the board.

In 2019, she joined the center for genome architecture at Baylor College of Medicine, where she got the opportunity to work on two very diverse projects; one of which was focused on the development of NGS-based diagnostic for SARS-CoV-2, and the other was to understand the crucial part of CTCF transcription factor that potentially interacts with cohesin protein to form chromatin loops.

An author and co-author of many peer-reviewed articles and a reviewer herself, Namita enjoys editing and reviewing scientific documents. She is interested in science outreach to the general audience. At the same time, she intends to communicate novel scientific discoveries to researchers and academic professionals. In her spare time, she loves to read and spend time with her daughter and family.

See less

Articles from Namita Mitra

Prior SARS-CoV-2 infection and risk of breakthrough infection following mRNA vaccination

Prior SARS-CoV-2 infection and risk of breakthrough infection following mRNA vaccination

Humoral and cell-mediated immunity six months post BNT162b2 vaccination

Humoral and cell-mediated immunity six months post BNT162b2 vaccination

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

SARS-CoV-2 antibodies persisting for nearly a year, including to delta: NZ study

SARS-CoV-2 antibodies persisting for nearly a year, including to delta: NZ study

How long does natural or vaccine-induced immunity to COVID last?

How long does natural or vaccine-induced immunity to COVID last?

Immune response to mRNA COVID vaccines delayed in pregnant women

Immune response to mRNA COVID vaccines delayed in pregnant women

Can targeting autophagy become a new approach to COVID-19 treatment?

Can targeting autophagy become a new approach to COVID-19 treatment?

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

A mucoadhesive polymer with anti-SARS-COV-2 activity in vitro and in vivo

A mucoadhesive polymer with anti-SARS-COV-2 activity in vitro and in vivo

Study suggests continued delta variant outbreaks unless vaccination reaches high coverage levels in adults and children

Study suggests continued delta variant outbreaks unless vaccination reaches high coverage levels in adults and children

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.